Digitum : Depósito de la Universidad de Murcia >
Revistas y Congresos >
Revistas >
Histology and histopathology >
Vol.22, nº 8 (2007) >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10201/27626
|
| Título: | Advances of MUC1 as a target for breast cancer immunotherapy |
| Issue Date: | 2007 |
| Editor/es: | Murcia : F. Hernández |
| Publicado en: | Histology and histopathology |
| ISSN: | 0213-3911 |
| Materias relacionadas: | 616 - Patología. Medicina clínica. Oncología |
| Palabras clave: | Immunotherapy Breast cancer |
| Resumen: | MUC1 is a potential target in breast cancer immunotherapy as MUC1 is overexpressed in breast cancer, and is absent or expressed in low level in normal mammary gland. In addition, MUC1 is mostly aberrantly underglycosylated in cancer and the antigens on the cancer surface are different from normal cell. Therefore targeting MUC1 for cancer immunotherapy can exploit the difference between cancer and normal cells, and eliminating the cancerous cells while leaving the normal mammary cells unharmed. This review will focus on the recent advance of MUC1 breast cancer immunotherapy currently being investigated. |
| Autor/es principal/es: | Yang, E. Hu, X.F. Xing, P.X. |
| Idioma: | en |
| URI: | http://hdl.handle.net/10201/27626 |
| Tipo de documento: | info:eu-repo/semantics/article |
| Número Páginas / Extensión: | 17 |
| Appears in Collections: | Vol.22, nº 8 (2007) |
Files in This Item:
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
© 2007-2013. DIGITUM. Depósito Digital Institucional de la Universidad de Murcia.
www.um.es | www.um.es/biblioteca | www.um.es/atica
